YOLFTbeta
Sky Labs Inc.

Sky Labs Inc.

386380 · KQ · Healthcare / Medical Devices

7,620.00KRW-370.00 (-4.63%)

Price History

Full chart

Market Stats

Previous Close7,990.00
Open7,990.00
Day Range7,580.00 – 8,250.00
52-Week Range8,200.00 – 39,350.00
Volume174.86K
Market Cap338.09B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
50-Day Avg23,014.76
200-Day Avg23,014.76

About

Sky Labs Inc. manufactures CART BP pro, a ring-type medical device as a blood pressure monitoring solution for healthcare professionals and patients. The company provides health monitoring services to prevent chronic disease as an AI healthcare platform company. Additionally, it develops CART ON, a healthcare platform that collects, analyzes, diagnoses, and distributes data from outpatients with chronic diseases. The company's device CART BP pro helps with accurate diagnosis and individualized medication by offering 24-hour ambulatory blood pressure monitoring data and health evaluation metrics. Sky Labs Inc. was founded in 2015 and is based in Seongnam-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Byunghwan Lee
  • Headquarters703, C?s Tower, 58, Seongnam-si, South Korea, 13486, Korea
  • Websitehttps://www.skylabs.io/en

Leadership

  • Mr. Byunghwan LeeCEO & Chairman · b. 1974
  • Ms. Sun-hee ParkC.B.O. & Head of Business Division · b. 1979
  • Mr. Bon-kwon KooC.S.O. (Clinical Research & Academic Affairs) · b. 1967

Financials

Income Statement

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Total Revenue480.63M589.27M4.09B7.94B
Growth (%)-+22.60%+594.22%+93.99%
Cost of Revenue2.01B1.89B5.16B4.03B
Gross Profit-1.53B-1.30B-1.07B3.91B
Gross Margin-318.56%-221.43%-26.21%49.27%
Operating Expense7.11B6.50B10.66B18.64B
Operating Income-8.64B-7.80B-11.73B-14.73B
Operating Margin-1797.16%-1323.71%-286.73%-185.55%
EBITDA-1.04B-10.18B-7.26B-55.61B
EBITDA Margin-216.11%-1727.16%-177.57%-700.76%
Net Income-3.50B-13.86B-12.67B-63.00B
Net Income Margin-727.31%-2351.73%-309.66%-793.80%
R&D2.33B2.78B4.91B9.78B
R&D as % of Total Revenue484.51%472.38%119.94%123.23%
Interest Expense2.02B2.85B4.52B6.22B
Interest Expense % of Total Revenue420.04%483.75%110.43%78.33%

Balance Sheet

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Total Assets11.68B25.34B27.48B30.18B
Total Liabilities43.26B70.26B83.83B4.73B
Total Equity-31.59B-44.92B-56.35B25.45B
Cash5.04B18.31B20.35B20.41B

Cash Flow

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-9.21B-6.59B-9.45B-12.93B
Capital Expenditure394.08M369.41M903.40M1.27B
Free Cash Flow-9.60B-6.96B-10.36B-14.19B
FCF to OCF104.28%105.60%109.56%109.80%

Key Statistics & Ratios

Market Cap338.09B
Enterprise Value423.15B
Trailing P/E0.00
Forward P/E0.00
Price / Sales48.35
Price / Book25.79
Revenue (TTM)0
Gross Profit (TTM)0
Profit Margin0.00%
Operating Margin0.00%
Return on Equity0.00%
Return on Assets0.00%
Shares Outstanding18.76M
Shares Float0
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%